Changes in tumor vascular permeability in response to experimental radioimmunotherapy: A comparative study of 11 xenografts

Tumor Biology

Volumn 18, Issue 6, 1997, Pages 367-377

  Blumenthal, Rosalyn D ^a   Sharkey, Robert M ^a   Kashi, Rina ^a   Sides, Keith ^a   Stein, Rhona ^a   Goldenberg, David M ^a  

^a GARDEN STATE CANCER CENTER   (United States)

Author keywords

Nude mouse; Radioimmunotherapy; Vascular permeability; Xenograft

Indexed keywords

ANTIBODY; ARGININE; CARCINOEMBRYONIC ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; FLUOROURACIL; FOLINIC ACID; GLYCOPROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RADIOACTIVE IODINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BREAST TUMOR; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; COLON CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG TUMOR; NONHUMAN; NUDE MOUSE; PANCREAS TUMOR; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOIMMUNOTHERAPY; RADIOIODINATION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; UTERINE CERVIX TUMOR;

EID: 0030666963     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000218051     Document Type: Article

References (37)

1. Begent RHJ: Recent advances in tumor imaging: Use of radiolabeled anti-tumor antibodies, Biochcm BiophysActa 1989:780:151-166.
2. Goldenberg DM: Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy, Semin Nucl Med 1989;19:332-339.
3. Cerriani RL, Blank EW: Experimental therapy of human breast tumors with 1311-labeled MAbs prepared against the human milk fat globule, Cancer Res 1988;48:4664-4672.
4. Sharkey RM, Pykett MJ, Siegel JA, Alger EA, Primus FJ, Goldenberg DM: Radioimmunotherapy of the GW-39 human colonic tumor xenograft with I-131-labeled murine monoclonal antibody to carcinocm-bryonic antigen, Cancer Res 1987; 47:5672-5677.
5. Denardo SJ, Warhoe KA, O’Grady LF, Hellstrom I, Hellstrom KE, Mills SL, Maccy DJ, Goodnight JE, Denardo GL: Radioimmunotherapy for breast cancer: Treatment of a patient with I-131-L6 chimeric monoclonal antibody, Ini J Biol Markers 1991;6:221 -230.
6. Hird V, Maraveyas A, Snook D: Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody, Br J Cancer 1993:68:403-406.
7. Blumenthal RD, Sharkey RM, Kashi R, Goldenberg DM: Comparison of the therapeutic efficacy and host toxicity of two different 1311-la-bcled antibodies and their fragments in the GW-39 colonic cancer xenograft model, Int J Cancer 1989:44: 292-300.
8. Blumenthal RD, Sharkey RM, Kashi R, Natale AM, Goldenberg DM: Physiological factors influencing radioantibody uptake: A study of four human colonic carcinomas, Int J Cancer 1992;51:935-941.
9. Fajardo LF, Berthrong M: Vascular lesions following radiation, Pathol Annu 1988;23:297-350.
10. Sands H, Jones PL, Shah L: Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clousner and renal-cell xenografts, Cancer Res 1988:48:188-193.
11. Law MP, Thomlinson RH, Chir B: Vascular permeability in the ears of rats after x-irradiation, Br J Radiol 1978;51:895-904.
12. Saeki Y, Shimazaki S, Urano M: Radiation effect on the vascularization of C3H mouse mammary carcinoma: Microangiographic studies of the tumor in preirradiated tissue and of the recurrent tumor, Radiology 1971;101:175-180.
13. Song CW, Levitt SR: Vascular changes in Walker 256 carcinoma of rats following x-irradiation, Radiology 1971;100:397-407.
14. Evans ML, Graham MM, Mahler PA, Rascy JS: Changes in vascular permeability following thorax irradiation in the rat, Radiat Res 1986; 107:262-271.
15. Eassa EHM, Casarett GW: Effect of epsilon-amino-n-caproic acid (EACA) on radiation-induced increase in capillary permeability, Radiology 1973;106:679-688.
16. Blumenthal RD, Sharkey RM, Kashi R, Goldenberg DM: Suppression of tumor vascular activity by radioantibody therapy: Implications for multiple treatment cycles, Select cancer Ther 1991;7:9-16.
17. Blumenthal RD, Kashi R, Sharkey RM, Goldenberg DM: Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeability, Int J Cancer 1995;61:557-566.
18. Goldenberg DM, Witte S, Elstcr K: GW-39: A new human tumor serially transplantable in the golden hamster, Transplantation 1966,4:610-614.
19. Blumenthal RD, Sharkey RM, Na-tale AM, Kashi R, Goldenberg DM: Comparison of equitoxic radioimmunotherapy and chemotherapy treatment of human colonic xenografts, Cancer Res 1994;54:142-151.
20. Gold DV, Nocera MA, Stephens R, Goldenberg DM: Murine monoclonal antibodies to colon-specific antigen p, Cancer Res 1990:50: 6405-6409.
21. Gold DV, Lew K, Maliniak R, Hernandez M, Cardillo T: Characterization of monoclonal antibody PAM4 reactive with a pancreatic cancer mucin, Int J Cancer 1994:57:204-210.
22. Stein R, Basau A, Chen S, Shih LB, Goldenberg DM: Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody, Int J Cancer 1993;55:938-946.
23. McConahey PJ, Dixon FJ: A method of trace radioiodination of proteins for immunologic purposes, Int Arch Allergy 1966;27:185-189.
24. Sharkey RM, Motta-Hennessy C, Pawlyk D, Siegel JA, Goldenberg DM: Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragment in nude mice bearing human colonic tumor xenografts, Cancer Res 1990:50:2230-2236.
25. Siegel JA, Stabin MG: Adsorbed fractions for electrons and beta particles in small spheres, J Nucl Med 1988:29:803-808.
26. Znati CA, Roscnstein M, Boucher Y, Epperly MW, Bloomer WD, Jain RK: Effect of radiation on interstitial fluid pressure and oxygenation in a human tumor xenograft, Cancer Res 1996:56:964-968.
27. Goda F, O'Hara JA, Rhodes ES, Liu KJ, Dunn JF, Bacic G, Swartz HM: Changes in oxygen tension in experimental tumors after a single dose of x-ray irradiation, Cancer Res 1995; 55:2249-2252.
28. Hetzel FW, Chopp M, Dereski MO: Variations in pCL and pH response to hyperthermia: Dependence on transplant site and duration of treatment, Radiat Res 1992; 131:152-156.
29. 90Y-carcinomcmbryonic antigen monoclonal antibody, Cancer Res 1991;51:3802-3806.
30. Boughton-Smith KK, Evans SM, Laszlo F, Whittle BJ R, Moncado S: The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat, Br J Pharmacol 1993:110:1189-1193.
31. Macda H, Noguchi Y, Sato K, Akaike T: Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor, Jpn J Cancer Res 1994;85:331-334.
32. Mayhan WG: Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5'diphosphate and bradykinin, Inflammation 1992;16:295-305.
33. Filep EG, Foldcs-Filcp E, Sirois P: Nitric oxide modulates vascular permeability in the rat coronary circulation, BrJ Pharmacol 1993; 108:323-326.
34. Kubcs P, Granger DN: Nitric oxide modulates microvascular permeability, Am J Physiol 1992;262: H611-H615.
35. Connolly DT, Heuvclman DM, Nelson R, Olander JV, Eppley BL, Del-fino JJ, Siegel NR, Leimgruber RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis, J Clin Invest 1989;84:1470-1478.
36. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA: Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels, J Exp Med 1991; 174: 1275-1278.
37. Roberts WG, Hasan T: Tumor secreted vascular permeability factor/ vascular endothelial growth factor influences photosensitizer uptake, Cancer Res 1993;53:153-157.